Generic placeholder image

Current Medicinal Chemistry - Anti-Cancer Agents

Editor-in-Chief

ISSN (Print): 1568-0118
ISSN (Online): 1875-5968

Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy

Author(s): K. Jin Yoon, Philip M. Potter and Mary K. Danks

Volume 5, Issue 2, 2005

Page: [107 - 113] Pages: 7

DOI: 10.2174/1568011053174837

Price: $65

Open Access Journals Promotions 2
Abstract

Anticancer enzyme / prodrug approaches to therapy are designed to activate prodrugs specifically at tumor loci, to achieve antitumor responses with minimal toxicity. The equivocal success of these approaches thus far has led to searches for more efficient combinations. This mini-review evaluates and compares characteristics of seven selected enzyme / prodrug combinations, and discusses goals for future development of effective combinations.

Keywords: enzyme prodrug therapy, hsv-tk gcv, Herves Simplex Virus-Thymidine Kinase Ganciclovir, cd 5-fc, cytosine deaminase 5-fluorocytosine, pnpase 2-f-araa, purine nucleoside phosphorylase 2-fluoroarabinosyl adenine

Next »

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy